Testing the feasibility of targeting a conserved region on the S2 domain of the SARS-CoV-2 spike protein
Description
The efficacy of vaccines against the SARS-CoV-2 virus significantly declines with the emergence of mutant strains, prompting investigation into the feasibility of targeting highly conserved but often cryptic regions on the S2 domain of spike protein
